Suchbegriffe: DRUG ADMINISTRATION SCHEDULE - , . Treffer: 170
McCarthy, O; Deere, R; Churm, R; Dunseath, GJ; Jones, C; Eckstein, ML; Williams, DM; Hayes, J; Pitt, J; Bain, SC; Moser, O; Bracken, RM
Extent and prevalence of post-exercise and nocturnal hypoglycemia following peri-exercise bolus insulin adjustments in individuals with type 1 diabetes.
NUTR METAB CARDIOVAS. 2021; 31(1): 227-236.
Doi: 10.1016/j.numecd.2020.07.043
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Eggermont, AMM; Rutkowski, P; Dutriaux, C; Hofman-Wellenhof, R; Dziewulski, P; Marples, M; Grange, F; Lok, C; Pennachioli, E; Robert, C; van Akkooi, ACJ; Bastholt, L; Minisini, A; Marshall, E; Salès, F; Grob, JJ; Bechter, O; Schadendorf, D; Marreaud, S; Kicinski, M; Suciu, S; Testori, AAE
Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial.
Eur J Cancer. 2020; 133(8):94-103
Doi: 10.1016/j.ejca.2020.04.015
Web of Science
PubMed
FullText
FullText_MUG
Amrein, K; Parekh, D; Westphal, S; Preiser, JC; Berghold, A; Riedl, R; Eller, P; Schellongowski, P; Thickett, D; Meybohm, P; VITDALIZE Collaboration Group
Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a study protocol of a multicentre, placebo-controlled double-blind phase III RCT (the VITDALIZE study).
BMJ Open. 2019; 9(11):e031083-e031083
Doi: 10.1136/bmjopen-2019-031083
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Freynhofer, MK; Hein-Rothweiler, R; Haller, PM; Aradi, D; Dézsi, DA; Gross, L; Orban, M; Trenk, D; Geisler, T; Huczek, Z; Toth-Gayor, GG; Massberg, S; Huber, K; Sibbing, D
Diurnal Variability of On-Treatment Platelet Reactivity in Clopidogrel versus Prasugrel Treated Acute Coronary Syndrome Patients: A Pre-Specified TROPICAL-ACS Sub-Study.
Thromb Haemost. 2019; 119(4):660-667
Doi: 10.1055/s-0038-1677549
Web of Science
PubMed
FullText
FullText_MUG
Lechleitner, M; Clodi, M; Abrahamian, H; Brath, H; Brix, J; Drexel, H; Fasching, P; Föger, B; Francesconi, C; Fröhlich-Reiterer, E; Harreiter, J; Hofer, SE; Hoppichler, F; Huber, J; Kaser, S; Kautzky-Willer, A; Ludvik, B; Luger, A; Mader, JK; Paulweber, B; Pieber, T; Prager, R; Rami-Merhar, B; Resl, M; Riedl, M; Roden, M; Saely, CH; Schelkshorn, C; Schernthaner, G; Sourij, H; Stechemesser, L; Stingl, H; Toplak, H; Wascher, TC; Weitgasser, R; Winhofer-Stöckl, Y; Zlamal-Fortunat, S
[Insulin therapy of type 2 diabetes mellitus (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):39-46
Doi: 10.1007/s00508-019-1492-7
Web of Science
PubMed
FullText
FullText_MUG
Skrabl-Baumgartner, A; Seidel, G; Langner-Wegscheider, B; Schlagenhauf, A; Jahnel, J
Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis.
Arch Dis Child. 2019; 104(3):246-250
Doi: 10.1136/archdischild-2018-315060
Web of Science
PubMed
FullText
FullText_MUG
Tomaniak, M; Chichareon, P; Onuma, Y; Deliargyris, EN; Takahashi, K; Kogame, N; Modolo, R; Chang, CC; Rademaker-Havinga, T; Storey, RF; Dangas, GD; Bhatt, DL; Angiolillo, DJ; Hamm, C; Valgimigli, M; Windecker, S; Steg, PG; Vranckx, P; Serruys, PW; GLOBAL LEADERS Trial Investigators
Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial.
JAMA Cardiol. 2019; 4(11):1092-1101
Doi: 10.1001/jamacardio.2019.3355
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Winter, MP; von Lewinski, D; Wallner, M; Prüller, F; Kolesnik, E; Hengstenberg, C; Siller-Matula, JM
Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study.
Sci Rep. 2019; 9(1):8194-8194
Doi: 10.1038/s41598-019-44673-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Aygören-Pürsün, E; Bygum, A; Grivcheva-Panovska, V; Magerl, M; Graff, J; Steiner, UC; Fain, O; Huissoon, A; Kinaciyan, T; Farkas, H; Lleonart, R; Longhurst, HJ; Rae, W; Triggiani, M; Aberer, W; Cancian, M; Zanichelli, A; Smith, WB; Baeza, ML; Du-Thanh, A; Gompels, M; Gonzalez-Quevedo, T; Greve, J; Guilarte, M; Katelaris, C; Dobo, S; Cornpropst, M; Clemons, D; Fang, L; Collis, P; Sheridan, W; Maurer, M; Cicardi, M
Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema.
NEW ENGL J MED. 2018; 379(4): 352-362.
Doi: 10.1056/NEJMoa1716995
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Dempster, DW; Brown, JP; Fahrleitner-Pammer, A; Kendler, D; Rizzo, S; Valter, I; Wagman, RB; Yin, X; Yue, SV; Boivin, G
Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis.
J Clin Endocrinol Metab. 2018; 103(7):2498-2509
Doi: 10.1210/jc.2017-02669
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Indolfi, G; Hierro, L; Dezsofi, A; Jahnel, J; Debray, D; Hadzic, N; Czubkowski, P; Gupte, G; Mozer-Glassberg, Y; van der Woerd, W; Smets, F; Verkade, HJ; Fischler, B
Treatment of Chronic Hepatitis C Virus Infection in Children: A Position Paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition.
J Pediatr Gastroenterol Nutr. 2018; 66(3):505-515
Doi: 10.1097/MPG.0000000000001872
Web of Science
PubMed
FullText
FullText_MUG
Leonardi, C; Maari, C; Philipp, S; Goldblum, O; Zhang, L; Burkhardt, N; Ball, S; Mallbris, L; Gonzalez, P; Fernández-Peñas, P; Puig, L
Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study.
J Am Acad Dermatol. 2018; 79(5):824-830
Doi: 10.1016/j.jaad.2018.05.032
Web of Science
PubMed
FullText
FullText_MUG
Mahla, E; Metzler, H; Bornemann-Cimenti, H; Prueller, F; Raggam, RB; Pregartner, G; Berghold, A; Baumann, A; Goeroeg, C; Gurbel, PA
Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study.
Thromb Haemost. 2018; 118(5):864-872
Doi: 10.1055/s-0038-1641153
Web of Science
PubMed
FullText
FullText_MUG
Mahla, E; Tantry, US; Prüller, F; Gurbel, PA
Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy?
Circulation. 2018; 138(19):2145-2159
Doi: 10.1161/CIRCULATIONAHA.118.035160
Web of Science
PubMed
FullText
FullText_MUG
Brozek, W; Reichardt, B; Zwerina, J; Dimai, HP; Klaushofer, K; Zwettler, E
Use of proton pump inhibitors and mortality after hip fracture in a nationwide study.
Osteoporos Int. 2017; 28(5):1587-1595
Doi: 10.1007/s00198-017-3910-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fahrleitner-Pammer, A; Papaioannou, N; Gielen, E; Feudjo Tepie, M; Toffis, C; Frieling, I; Geusens, P; Makras, P; Boschitsch, E; Callens, J; Anastasilakis, AD; Niedhart, C; Resch, H; Kalouche-Khalil, L; Hadji, P
Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium.
Arch Osteoporos. 2017; 12(1):58-58
Doi: 10.1007/s11657-017-0351-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fung, P; Bedogni, G; Bedogni, A; Petrie, A; Porter, S; Campisi, G; Bagan, J; Fusco, V; Saia, G; Acham, S; Musto, P; Petrucci, MT; Diz, P; Colella, G; Mignogna, MD; Pentenero, M; Arduino, P; Lodi, G; Maiorana, C; Manfredi, M; Hallberg, P; Wadelius, M; Takaoka, K; Leung, YY; Bonacina, R; Schiødt, M; Lakatos, P; Taylor, T; De Riu, G; Favini, G; Rogers, SN; Pirmohamed, M; Nicoletti, P; GENVABO Consortium; Fedele, S
Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study.
Oral Dis. 2017; 23(4):477-483
Doi: 10.1111/odi.12632
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Holman, RR; Bethel, MA; Mentz, RJ; Thompson, VP; Lokhnygina, Y; Buse, JB; Chan, JC; Choi, J; Gustavson, SM; Iqbal, N; Maggioni, AP; Marso, SP; Öhman, P; Pagidipati, NJ; Poulter, N; Ramachandran, A; Zinman, B; Hernandez, AF; EXSCEL Study Group
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med. 2017; 377(13): 1228-1239.
Doi: 10.1056/NEJMoa1612917
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mueller, RB; Graninger, W; Sidiropoulos, P; Goger, C; von Kempis, J
Median time to low disease activity is shorter in tocilizumab combination therapy with csDMARDs as compared to tocilizumab monotherapy in patients with active rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: sub-analysis of the Swiss and Austrian patients from the ACT-SURE study.
Clin Rheumatol. 2017; 36(10):2187-2192
Doi: 10.1007/s10067-017-3779-2
Web of Science
PubMed
FullText
FullText_MUG
Palkovits, S; Seidel, G; Pertl, L; Malle, EM; Hausberger, S; Makk, J; Singer, C; Osterholt, J; Herzog, SA; Haas, A; Weger, M
MACULAR CHOROIDAL VOLUME CHANGES AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Retina. 2017; 37(12):2262-2268
Doi: 10.1097/IAE.0000000000001480
Web of Science
PubMed
FullText
FullText_MUG
Pölzl, G; Altenberger, J; Baholli, L; Beltrán, P; Borbély, A; Comin-Colet, J; Delgado, JF; Fedele, F; Fontana, A; Fruhwald, F; Giamouzis, G; Giannakoulas, G; Garcia-González, MJ; Gustafsson, F; Kaikkonen, K; Kivikko, M; Kubica, J; von Lewinski, D; Löfman, I; Malfatto, G; Manito, N; Martínez-Sellés, M; Masip, J; Merkely, B; Morandi, F; Mølgaard, H; Oliva, F; Pantev, E; Papp, Z; Perna, GP; Pfister, R; Piazza, V; Bover, R; Rangel-Sousa, D; Recio-Mayoral, A; Reinecke, A; Rieth, A; Sarapohja, T; Schmidt, G; Seidel, M; Störk, S; Vrtovec, B; Wikström, G; Yerly, P; Pollesello, P
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.
Int J Cardiol. 2017; 243(3):389-395
Doi: 10.1016/j.ijcard.2017.05.081
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Sezer, O; Beksac, M; Hajek, R; Sucak, G; Cagirgan, S; Linkesch, W; Meltem Akay, O; Gülbas, Z; Nahi, H; Plesner, T; Snowden, JA; Timurağaoğlu, A; Dechow, T; Lang, A; Tuğlular, T; Drach, J; Armbrecht, G; Potamianou, A; Couturier, C; Olie, RA; Feys, C; Allietta, N; Terpos, E
Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
Br J Haematol. 2017; 178(1):61-71
Doi: 10.1111/bjh.14637
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Sticherling, M; Franke, A; Aberer, E; Gläser, R; Hertl, M; Pfeiffer, C; Rzany, B; Schneider, S; Shimanovich, I; Werfel, T; Wilczek, A; Zillikens, D; Schmidt, E
An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone.
Br J Dermatol. 2017; 177(5):1299-1305
Doi: 10.1111/bjd.15649
Web of Science
PubMed
FullText
FullText_MUG
Abrahamian, H; Kautzky-Willer, A; Rießland-Seifert, A; Fasching, P; Ebenbichler, C; Hofmann, P; Toplak, H
[Mental disorders and diabetes mellitus].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S170-S178
Doi: 10.1007/s00508-015-0939-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Bethel, MA; Harrison, P; Sourij, H; Sun, Y; Tucker, L; Kennedy, I; White, S; Hill, L; Oulhaj, A; Coleman, RL; Holman, RR
Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.
Diabet Med. 2016; 33(2):224-230
Doi: 10.1111/dme.12828
Web of Science
PubMed
FullText
FullText_MUG
Blevins, T; Pieber, TR; Colón Vega, G; Zhang, S; Bastyr, EJ; Chang, AM; IMAGINE 4 Investigators
Randomized double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 2 diabetes: IMAGINE 4.
Diabetes Obes Metab. 2016; 18(11):1072-1080
Doi: 10.1111/dom.12696
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Bohn, B; Karges, B; Vogel, C; Otto, KP; Marg, W; Hofer, SE; Fröhlich-Reiterer, E; Holder, M; Plamper, M; Wabitsch, M; Kerner, W; Holl, RW; DPV Initiative
20 Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 Diabetes.
PLoS One. 2016; 11(8):e0160971-e0160971
Doi: 10.1371/journal.pone.0160971
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Buttgereit, F; Dejaco, C; Matteson, EL; Dasgupta, B
Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
JAMA. 2016; 315(22):2442-2458
Doi: 10.1001/jama.2016.5444
Web of Science
PubMed
FullText
FullText_MUG
Clodi, M; Abrahamian, H; Drexel, H; Fasching, P; Föger, B; Francesconi, C; Hoppichler, F; Kaser, S; Kautzky-Willer, A; Lechleitner, M; Ludvik, B; Prager, R; Fröhlich-Reiterer, E; Roden, M; Säly, C; Schernthaner, G; Sourij, H; Toplak, H; Wascher, TC; Weitgasser, R
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S45-S53
Doi: 10.1007/s00508-016-0991-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fabian, E; Bordag, N; Herold, M; Kamp, H; Krennrich, G; Looser, R; Ma-Hock, L; Mellert, W; Montoya, G; Peter, E; Prokudin, A; Spitzer, M; Strauss, V; Walk, T; Zbranek, R; van Ravenzwaay, B
Metabolite profiles of rats in repeated dose toxicological studies after oral and inhalative exposure.
Toxicol Lett. 2016; 255: 11-23.
Doi: 10.1016/j.toxlet.2016.05.003
Web of Science
PubMed
FullText
FullText_MUG
Goldinger, SM; Gobbi Bischof, S; Fink-Puches, R; Klemke, CD; Dréno, B; Bagot, M; Dummer, R
Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial.
JAMA Dermatol. 2016; 152(7):837-839
Doi: 10.1001/jamadermatol.2016.0401
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Heise, T; Korsatko, S; Nosek, L; Coester, HV; Deller, S; Roepstorff, C; Segel, S; Kapur, R; Haahr, H; Hompesch, M
Steady state is reached within 2-3 days of once-daily administration of degludec, a basal insulin with an ultralong duration of action.
J Diabetes. 2016; 8(1):132-138
Doi: 10.1111/1753-0407.12266
Web of Science
PubMed
FullText
FullText_MUG
Holman, RR; Bethel, MA; George, J; Sourij, H; Doran, Z; Keenan, J; Khurmi, NS; Mentz, RJ; Oulhaj, A; Buse, JB; Chan, JC; Iqbal, N; Kundu, S; Maggioni, AP; Marso, SP; Öhman, P; Pencina, MJ; Poulter, N; Porter, LE; Ramachandran, A; Zinman, B; Hernandez, AF
Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial.
Am Heart J. 2016; 174(6):103-110
Doi: 10.1016/j.ahj.2015.12.009
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Klamroth, R; Simpson, M; von Depka-Prondzinski, M; Gill, JC; Morfini, M; Powell, JS; Santagostino, E; Davis, J; Huth-Kühne, A; Leissinger, C; Neumeister, P; Bensen-Kennedy, D; Feussner, A; Limsakun, T; Zhou, M; Veldman, A; St Ledger, K; Blackman, N; Pabinger, I
Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(®) ) in patients with severe haemophilia A.
Haemophilia. 2016; 22(5):730-738
Doi: 10.1111/hae.12985
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Moinzadeh, P; Riemekasten, G; Siegert, E; Fierlbeck, G; Henes, J; Blank, N; Melchers, I; Mueller-Ladner, U; Frerix, M; Kreuter, A; Tigges, C; Lahner, N; Susok, L; Guenther, C; Zeidler, G; Pfeiffer, C; Worm, M; Karrer, S; Aberer, E; Bretterklieber, A; Genth, E; Simon, JC; Distler, JH; Hein, R; Schneider, M; Seitz, CS; Herink, C; Steinbrink, K; Sárdy, M; Varga, R; Mensing, H; Mensing, C; Lehmann, P; Neeck, G; Fiehn, C; Weber, M; Goebeler, M; Burkhardt, H; Buslau, M; Ahmadi-Simab, K; Himsel, A; Juche, A; Koetter, I; Kuhn, A; Sticherling, M; Hellmich, M; Kuhr, K; Krieg, T; Ehrchen, J; Sunderkoetter, C; Hunzelmann, N; German Network for Systemic Scleroderma
Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients.
J Rheumatol. 2016; 43(1):66-74
Doi: 10.3899/jrheum.150382
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Novacek, G; Dejaco, C; Gröchenig, HP; Högenauer, C; Knoflach, P; Miehsler, W; Moschen, A; Petritsch, W; Vogelsang, H; Tilg, H
[In Process Citation].
Z Gastroenterol. 2016; 54(5):456-467
Doi: 10.1055/s-0042-103694
Web of Science
PubMed
FullText
FullText_MUG
Radda, S; Bolz, M; Egger, S; Gasser-Steiner, V; Kralinger, M; Mennel, S; Scholda, C; Stolba, U; Wedrich, A; Krepler, K
[Diagnosis, treatment and monitoring of diabetic eye control].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S97-102
Doi: 10.1007/s00508-016-0983-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, SE
Diabetes in the youth].
Wien Klin Wochenschr. 2016; 128 Suppl 2(3):S119-S123
Doi: 10.1007/s00508-015-0922-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Rodbard, HW; Cariou, B; Pieber, TR; Endahl, LA; Zacho, J; Cooper, JG
Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co-formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trial.
Diabetes Obes Metab. 2016; 18(3):274-280
Doi: 10.1111/dom.12609
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schernthaner, G; Drexel, H; Rosenkranz, A; Schernthaner, GH; Watschinger, B
Antihypertensive therapy in diabetes mellitus: Guidelines of the Austrian Diabetes Association 2016].
Wien Klin Wochenschr. 2016; 128 Suppl 2(21):S62-S67
Doi: 10.1007/s00508-015-0924-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Stadler, M; Zlamal-Fortunat, S; Schütz-Fuhrmann, I; Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, S; Mader, J; Resl, M; Kautzky-Willer, A; Weitgasser, R; Prager, R; Bischof, M
[Insulin pump therapy in children, adolescents and adults].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S188-S195
Doi: 10.1007/s00508-016-0966-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Toplak, H; Hoppichler, F; Wascher, TC; Schindler, K; Ludvik, B
[Obesity and type 2 diabetes].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S196-S200
Doi: 10.1007/s00508-016-0986-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wascher, TC; Paulweber, B; Toplak, H; Säly, CH; Drexel, H; Föger, B; Hoppichler, F
[Lipids--Diagnosis and therapy in diabetes mellitus].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S68-S70
Doi: 10.1007/s00508-015-0933-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Weiss, TW; Aichinger, J; Huber, K; Speidl, WS; Watzinger, N; Zweiker, R; Alber, HF
Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction.
Wien Klin Wochenschr. 2016; 128(11-12):450-457
Doi: 10.1007/s00508-016-1016-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Dejaco, C; Singh, YP; Perel, P; Hutchings, A; Camellino, D; Mackie, S; Abril, A; Bachta, A; Balint, P; Barraclough, K; Bianconi, L; Buttgereit, F; Carsons, S; Ching, D; Cid, M; Cimmino, M; Diamantopoulos, A; Docken, W; Duftner, C; Fashanu, B; Gilbert, K; Hildreth, P; Hollywood, J; Jayne, D; Lima, M; Maharaj, A; Mallen, C; Martinez-Taboada, V; Maz, M; Merry, S; Miller, J; Mori, S; Neill, L; Nordborg, E; Nott, J; Padbury, H; Pease, C; Salvarani, C; Schirmer, M; Schmidt, W; Spiera, R; Tronnier, D; Wagner, A; Whitlock, M; Matteson, EL; Dasgupta, B; European League Against Rheumatism; American College of Rheumatology
2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
Ann Rheum Dis. 2015; 74(10):1799-1807
Doi: 10.1136/annrheumdis-2015-207492
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Dejaco, C; Singh, YP; Perel, P; Hutchings, A; Camellino, D; Mackie, S; Matteson, EL; Dasgupta, B
Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica.
Ann Rheum Dis. 2015; 74(10):1808-1817
Doi: 10.1136/annrheumdis-2015-207578
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hadji, P; Papaioannou, N; Gielen, E; Feudjo Tepie, M; Zhang, E; Frieling, I; Geusens, P; Makras, P; Resch, H; Möller, G; Kalouche-Khalil, L; Fahrleitner-Pammer, A
Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
Osteoporos Int. 2015; 26(10):2479-2489
Doi: 10.1007/s00198-015-3164-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hilbe, W; Pall, G; Kocher, F; Pircher, A; Zabernigg, A; Schmid, T; Schumacher, M; Jamnig, H; Fiegl, M; Gächter, A; Freund, M; Kendler, D; Manzl, C; Zelger, B; Popper, H; Wöll, E
Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study).
PLoS One. 2015; 10(5):e0125364-e0125364
Doi: 10.1371/journal.pone.0125364
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Longhurst, HJ; Aberer, W; Bouillet, L; Caballero, T; Fabien, V; Zanichelli, A; Maurer, M; IOS Investigators
Analysis of characteristics associated with reinjection of icatibant: Results from the icatibant outcome survey.
Allergy Asthma Proc. 2015; 36(5):399-406
Doi: 10.2500/aap.2015.36.3892
Web of Science
PubMed
FullText
FullText_MUG
Marovt, M; El Shabrawi-Caelen, L
Purpuric bullous pemphigoid.
Am J Dermatopathol. 2015; 37(2):e18-e20
Doi: 10.1097/DAD.0000000000000057
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Weitere 50 Treffer anzeigen